Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
377 IL-15 treatment enhances the in vivo anti-tumor efficacy of sipuleucel-T by activating CD8+ T and NKT effector cells, augmenting tumor infiltration, and reversing immunoresistance pathways
Compose a Response to This Article
Other responses
No responses have been published for this article.
